קפסיטבין אינובמד 500 מג
inovamed ltd - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine
קפסיטבין אינובמד 500 מג
inovamed ltd - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine
רפאסאל 500 מג קפליות
rafa laboratories ltd - mesalazine - caplets - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.
רפאסאל 500 מג פתילות
rafa laboratories ltd - mesalazine - פתילות - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.
פנטסה טבליות בשחרור איטי 500 מג
ferring pharmaceuticals ltd - mesalazine - טבליות בשחרור איטי - mesalazine 500 mg - mesalazine - mesalazine - ulcerative colitis. crohn's disease.
ג'נואט 50/500 מ"ג טבליות
merck sharp & dohme israel ltd - metformin hydrochloride 500 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.
ג'נואט 50/500 מ"ג טבליות
merck sharp & dohme israel ltd - metformin hydrochloride 500 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.
ג'נואט 50/500 מ"ג טבליות
merck sharp & dohme israel ltd - metformin hydrochloride 500 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.
נובוגרד 1 מ"ג/500 מ"ג
novo nordisk ltd - metformin hydrochloride 500 mg; repaglinide 1 mg - tablets - metformin - novogard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin hcl or who have inadequate glycemic control on a meglitinide alone or metformin hcl alone.
נובוגרד 2 מ"ג/500 מ"ג
novo nordisk ltd - metformin hydrochloride 500 mg; repaglinide 2 mg - tablets - metformin - novogard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin hcl or who have inadequate glycemic control on a meglitinide alone or metformin hcl alone.